AbbVie Inc (ABBV.N)
22 Feb 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|63||2013||Chairman of the Board, Chief Executive Officer|
|49||2013||Executive Vice President, Chief Financial Officer|
|51||2014||Executive Vice President - Research & Development, Chief Scientific Officer|
|53||2013||Executive Vice President, External Affairs, General Counsel and Corporate Secretary|
|54||2013||Executive Vice President - Commercial Operations|
- BRIEF-Abbvie Canada Says Canadians Diagnosed With Advanced Parkinson's Disease Living In Nova Scotia Now Have Public Access To Duodopa
- BRIEF-Abbvie Announces Positive Topline Results From Phase 3 Study Evaluating Investigational Elagolix In Women With Uterine Fibroids
- BRIEF-Voyager Therapeutics And Abbvie Announce Global Strategic Collaboration
- BRIEF-Abbvie Announces New Phase 2 Data For Upadacitinib Showing Clinical And Endoscopic Outcomes In Crohn's Disease At 52 Weeks
- AbbVie to buy back $10 billion of shares, raises dividend